Rapid report
Human stefin B readily forms amyloid fibrils in vitro

https://doi.org/10.1016/S0167-4838(01)00295-3Get rights and content

Abstract

Human stefin B (cystatin B) is an intracellular cysteine proteinase inhibitor broadly distributed in different tissues. Here, we show that recombinant human stefin B readily forms amyloid fibrils in vitro. It dimerises and further oligomerises, starting from the native-like acid intermediate, IN, populated at pH 5. On standing at room temperature it produces regular (over 4 μm long) fibrils over a period of several months. These have been visualised by transmission electron microscopy and atomic force microscopy. Their cross-sectional diameter is about 14 nm and blocks of 27 nm repeat longitudinally. The fibrils are smooth, of unbranched surface, consistent with findings of other amyloid fibrils. Thioflavin T fluorescence spectra as a function of time were recorded and Congo red dye binding to the fibrils was demonstrated. Adding 10% (v/v) trifluoroethanol resulted in an increased rate of fibrillation with a typical lag phase. The finding that human stefin B, in contrast to the homologue stefin A, forms amyloid fibrils rather easily should promote further studies of the protein’s behaviour in vivo, and/or as a model system for fibrillogenesis.

References (40)

  • J.W. Kelly

    Curr. Opin. Struct. Biol.

    (1998)
  • C.M. Dobson

    Trends Biochem. Sci.

    (1999)
  • M. Goedert et al.

    Curr. Opin. Neurobiol.

    (1998)
  • A. Alves-Rodrigues et al.

    Trends Neurosci.

    (1998)
  • J.C. Rochet et al.

    Curr. Opin. Struct. Biol.

    (2000)
  • T.T. Ding et al.

    Methods Enzymol.

    (1999)
  • L.C. Serpell

    Biochim. Biophys. Acta

    (2000)
  • V. Turk et al.

    FEBS Lett.

    (1991)
  • J.R. Martin et al.

    J. Mol. Biol.

    (1995)
  • E. Žerovnik et al.

    Biochim. Biophys. Acta

    (1994)
  • R. Jerala et al.

    J. Mol. Biol.

    (1999)
  • M. Riccio et al.

    Exp. Cell Res.

    (2001)
  • W.E. Klunk et al.

    Methods Enzymol.

    (1999)
  • H. Le Vine

    Methods Enzymol.

    (1999)
  • E. Žerovnik et al.

    J. Biol. Chem.

    (1992)
  • K. Shiraki et al.

    J. Mol. Biol.

    (1995)
  • T. Konno et al.

    FEBS Lett.

    (1999)
  • P.T. Lansbury

    Proc. Natl. Acad. Sci. USA

    (1999)
  • J.W. Kelly

    Nat. Struct. Biol.

    (2000)
  • R.W. Carrel et al.

    Curr. Opin. Struct. Biol.

    (1998)
  • Cited by (72)

    • Limited Proteolysis Reveals That Amyloids from the 3D Domain-Swapping Cystatin B Have a Non-Native β-Sheet Topology

      2015, Journal of Molecular Biology
      Citation Excerpt :

      Human cystatin C cerebral amyloid angiopathy is a hereditary disease caused by the L68Q mutation in the protein [17]. This mutant protein is difficult to purify and manipulate [18]; therefore, wild-type cystatin B has often been used as a model for amyloid formation in the cystatin family [19]. Perhaps more importantly, as a small folded protein, cystatin proves to be an ideal system to improve our understanding of how folded proteins form amyloid.

    • Gain in toxic function of stefin B EPM1 mutants aggregates: Correlation between cell death, aggregate number/size and oxidative stress

      2014, Biochimica et Biophysica Acta - Molecular Cell Research
      Citation Excerpt :

      Additionally to the loss of function that occurs, gain in toxic function of some EPM1 stefin B missense mutant aggregates may play a role, as proposed by us before [41]. Stefin B in its wild type (wt) form is an amyloidogenic protein and it has served as an appropriate model for studies of amyloid formation [42,43]. Protein misfolding and aggregation are at the core of the so called conformational disorders [44,45].

    • Insights in progressive myoclonus epilepsy: HSP70 promotes cystatin B polymerization

      2013, Biochimica et Biophysica Acta - Proteins and Proteomics
    • The cross-road between the mechanisms of protein folding and aggregation; study of human stefin B and its H75W mutant

      2011, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      For the H75W mutant the folding to the same native-like intermediate took place at pH 7 (in 3 phases) while at pH 4.8 and 5.8 the mutant ended in another intermediate state, molten globule-like, which did not fold any further. The H75W mutant was prone to aggregate to amorphous aggregate at this pH and did not form mature fibrils (TEM data not shown), in accordance to intermediate of the molten globule type formed by the stefin B at pH 3 [24,25]. For the case of stefins, we have shown that different folding intermediates build fibrils of different morphology [25] and some may be off-pathway [23].

    View all citing articles on Scopus
    View full text